Mankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in the country. The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion, distribution is by Mankind Pharma, the company said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3EzFgX1
via IFTTT
0 comments:
Post a Comment